Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these
Pneumonia Drug Development Pipeline Review, 2017
Pneumonia Drug Development Pipeline Review, 2017 This report provides an overview of the pipeline landscape for pneumonia disorders.
Sleep Disorders Drug Development Pipeline Review, 2017
Sleep Disorders Drug Development Pipeline Review, 2017 This report provides an overview of the pipeline landscape for sleep disorders.
Male Health Drug Development Pipeline Review, 2017
Male Health Drug Development Pipeline Review, 2017 This report provides an overview of the pipeline landscape for male health.
Colorectal Cancer Drug Development Pipeline Review, 2017
Colorectal Cancer Drug Development Pipeline Review, 2017 This report provides an overview of the colorectal cancer pipeline landscape.
Behavioral Disorders Drug Development Pipeline Review, 2017
Behavioral Disorders Drug Development Pipeline Review, 2017 This report provides an overview of the behavioral disorders pipeline landscape.
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as inflammation, the scarring of lung tissue and excessive production of mucus in the airways
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
Cancer is a group of diseases that are defined by abnormal cell growth, local tissue invasion and eventual migration to other parts of the body
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
The hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR) and dry eye syndrome (DES)
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape
Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV), which can lead to acute and chronic hepatitis infection
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for genetic ophthalmological disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Stargardt disease, Leber congenital amaurosis, Leber’s hereditary optic neuropathy, Usher Syndrome and Retinitis pigmentosa, and features dormant and discontinued projects
Hepatitis Drug Development Pipeline Review, 2017
This report provides an overview of the hepatitis pipeline landscape
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for neuropsychiatric disorders
Pain Drug Development Pipeline Review, 2017
This report provides an overview of the pain pipeline landscape
Read More »Skeletal Disease Drug Development Pipeline Review, 2017
This report provides an overview of the skeletal disease pipeline landscape
Read More »Transplantation Drug Development Pipeline Review, 2017
This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease
Read More »Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis
Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist, ranging from the autoimmune disorder psoriasis to the very common condition acne vulgaris.
Read More »Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally
Read More »